Microbot Stock Analysis


USD 4.51  0.08  1.74%   

The small drop in market price for the last few months may encourage private investors to take a closer look at the firm as it is trading at a share price of 4.51 on 5,615 in trading volume. The company management teams did not add much value to Microbot Medical investors in November. However, diversifying your holdings with Microbot Medical or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.54. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Microbot Medical partners.
Additionally, see Correlation Analysis.
The Microbot Medical stock analysis report makes it easy to digest most publicly released information about Microbot Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Microbot Stock analysis module also helps to analyze the Microbot Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Microbot Stock Analysis Notes

About 21.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.7. Microbot Medical last dividend was issued on the 5th of September 2018. The entity had 1:15 split on the 5th of September 2018. Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Microbot Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 20 people. To find out more about Microbot Medical contact Harel Gadot at 781 875 3605 or learn more at https://www.microbotmedical.com.

Microbot Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Microbot Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Microbot Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Microbot Medical generated a negative expected return over the last 90 days
Microbot Medical has high historical volatility and very poor performance
Net Loss for the year was (11.31 M) with profit before overhead, payroll, taxes, and interest of 0.
Microbot Medical currently holds about 9.29 M in cash with (9.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Microbot Medical has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Microbot Medical Gets US Patent Allowance for Liberty System Interface Design - Marketscreener.com

Microbot Medical Upcoming and Recent Events

Earnings reports are used by Microbot Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Microbot Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report30th of March 2022
Next Financial Report16th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End30th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Microbot Largest EPS Surprises

Earnings surprises can significantly impact Microbot Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Microbot Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Microbot Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Microbot Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Microbot Medical specific information freely available to individual and institutional investors to make a timely investment decision.
19th of September 2022
Financial Statements and Exhibits. Regulation FD Disclosure
15th of September 2022
Financial Statements and Exhibits. Regulation FD Disclosure
13th of September 2022
Financial Statements and Exhibits. Regulation FD Disclosure
12th of September 2022
Financial Statements and Exhibits. Regulation FD Disclosure
8th of September 2022
Financial Statements and Exhibits. Regulation FD Disclosure
6th of September 2022
Financial Statements and Exhibits. Regulation FD Disclosure
2nd of September 2022
Financial Statements and Exhibits. Regulation FD Disclosure
18th of August 2022
Financial Statements and Exhibits. Regulation FD Disclosure

Microbot Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Microbot Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Microbot Medical backward and forwards among themselves. Microbot Medical's institutional investor refers to the entity that pools money to purchase Microbot Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zeke Capital Advisors LlcCommon Shares40 K30 K
Zeke Capital Advisors LlcCommon Shares40 K27 K
Zeke Capital Advisors LlcCommon Shares40 K41 K
Xxec IncCommon Shares92.6 K788 K
Xxec IncCommon Shares92.6 K638 K
Xxec IncCommon Shares95.8 K761 K
Wfg Advisors LpCommon Shares30.00.0
Note, although Microbot Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Microbot Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 35.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbot Medical's market, we take the total number of its shares issued and multiply it by Microbot Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Microbot Profitablity

Microbot Medical's profitability indicators refer to fundamental financial ratios that showcase Microbot Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Microbot Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Microbot Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Microbot Medical's profitability requires more research than a typical breakdown of Microbot Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Investment(180.05) (194.27) 
Return on Average Assets(52.56) (56.71) 
Return on Average Equity(58.48) (63.10) 
Return on Invested Capital(2.42) (2.61) 
Return on Sales(27.95) (30.16) 

Management Efficiency

The entity has return on total asset (ROA) of (0.6524) % which means that it has lost $0.6524 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (1.1989) %, meaning that it created substantial loss on money invested by shareholders. Microbot Medical management efficiency ratios could be used to measure how well microbot medical manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to drop to -194.27 in 2022. Return on Average Assets is likely to drop to -56.71 in 2022. Total Liabilities is likely to gain to about 2.4 M in 2022. Current Liabilities is likely to gain to about 2 M in 2022
Last ReportedProjected for 2022
Book Value per Share 2.02  2.08 
Enterprise Value over EBIT(4.00) (4.32) 
Enterprise Value over EBITDA(3.60) (3.89) 
Price to Book Value 3.71  4.00 
Tangible Assets Book Value per Share 2.36  2.42 
Enterprise Value40.5 M34 M
Tangible Asset Value16.8 M17.2 M

Technical Drivers

As of the 3rd of December, Microbot Medical secures the mean deviation of 2.46, and Risk Adjusted Performance of (0.042179). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Microbot Medical, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Microbot Medical, which can be compared to its peers in the industry. Please verify Microbot Medical variance, as well as the relationship between the value at risk and skewness to decide if Microbot Medical is priced some-what accurately, providing market reflects its recent price of 4.51 per share. Given that Microbot Medical has jensen alpha of (0.21), we recommend you to check Microbot Medical's last-minute market performance to make sure the company can sustain itself at a future point.

Microbot Medical Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. Microbot Medical Triple Exponential Moving Average indicator shows smoothing effect of Microbot Medical price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Microbot Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Microbot Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Microbot Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Microbot Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Microbot Medical Predictive Daily Indicators

Microbot Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Microbot Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Microbot Medical Forecast Models

Microbot Medical time-series forecasting models is one of many Microbot Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Microbot Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Microbot Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Microbot Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Microbot shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Microbot Medical. By using and applying Microbot Stock analysis, traders can create a robust methodology for identifying Microbot entry and exit points for their positions.
Last ReportedProjected for 2022
Gross Margin 84.74  91.65 

Current Microbot Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Microbot analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Microbot analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
20.0Strong Buy1Odds
Microbot Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Microbot analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Microbot stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Microbot Medical, talking to its executives and customers, or listening to Microbot conference calls.
Microbot Analyst Advice Details

Microbot Stock Analysis Indicators

Microbot Medical stock analysis indicators help investors evaluate how Microbot Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Microbot Medical shares will generate the highest return on investment. By understating and applying Microbot Medical stock analysis, traders can identify Microbot Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow19734000.00
Logo U R LimglogosUSMBOT.png
Common Stock Shares Outstanding7108133.00
Total Stockholder Equity14381000.00
Total Cashflows From Investing Activities3200000.00
Property Plant And Equipment Net888000.00
Retained Earnings-55593000.00
Cash And Short Term Investments15492000.00
Accounts Payable279000.00
Net Debt-12813000.00
50 Day M A4.3976
Total Current Liabilities1984000.00
Currency CodeUSD
Other Operating Expenses11357000.00
Non Current Assets Total888000.00
Additionally, see Correlation Analysis. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for analysis

When running Microbot Medical price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Transaction History
View history of all your transactions and understand their impact on performance
Is Microbot Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Microbot Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.